Disciplined Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13
Closed -$1.83K 481
2023
Q2
$1.83K Sell
13
-5
-28% -$689 ﹤0.01% 699
2023
Q1
$2.55K Sell
18
-3
-14% -$429 ﹤0.01% 580
2022
Q4
$3.29K Buy
21
+5
+31% +$719 ﹤0.01% 471
2022
Q3
$2K Sell
16
-2
-11% -$263 ﹤0.01% 608
2022
Q2
$2K Sell
18
-1
-5% -$136 ﹤0.01% 636
2022
Q1
$3K Buy
+19
New +$2.65K ﹤0.01% 565

Other funds holding DGX

Disciplined Investments's DGX Position: Q3 2023 in Review

Disciplined Investments sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 13 shares — an estimated $1.83K sold.

Disciplined Investments first reported a position in DGX in Q1 2022 and held it in 6 quarters. The position peaked at $3.29K in Q4 2022. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Disciplined Investments reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 13 Quest Diagnostics shares in Q3 2023, an estimated $1.83K.
  • Disciplined Investments first reported a position in Quest Diagnostics in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Quest Diagnostics position peaked at $3.29K in Q4 2022.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.